Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
Karl Koster welcomes attendees to Robotics workshop.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Rei Goffer, Cofounder & Chief Strategy Officer, ClimaCell
Alec Shkolnik, CoFounder and CEO, LiquidPiston
James Gado, Senior Director, MIT Corporate Relations